Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activity

Details for Australian Patent Application No. 2010303441 (hide)

Owner Bristol-Myers Squibb Company

Inventors Hynes, John; Carter, Percy H.; Cornelius, Lyndon A.M.; Dhar, T.G. Murali; Duncia, John V.; Nair, Satheesh; Santella, Joseph B.; Warrier, Jayakumar S.; Wu, Hong

Agent A J Park

Pub. Number AU-A-2010303441

PCT Pub. Number WO2011/044309

Priority 61/249,270 07.10.09 US

Filing date 7 October 2010

Wipo publication date 14 April 2011

International Classifications

C07D 211/52 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

3 May 2012 PCT application entered the National Phase

  PCT publication WO2011/044309 Priority application(s): WO2011/044309

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010303443-Generation, characterization and uses thereof of anti-Her 3 antibodies

2010303439-Phenyloxadiazole derivatives as PGDS inhibitors